logo
  

Ford Sept Total U.S. Sales Down 17.7% - Quick Facts

Ford Motor Co. (F) said Monday that total U.S. sales for the month of September 2021 decreased 17.7% to 156,614 vehicles from 190,233 vehicles in the same month last year. Ford's September retail sales were also down 20.8%. New products and improved inventory propelled Ford to be the top-selling Automaker in September.

Ford brand vehicle sales in September declined 17.5% to 148,967 units and Lincoln brand vehicle sales also decreased 20.9% to 7,647 units from last year.

Truck sales for the month declined 22.6% to 83,554 units and Car sales plunged 80.3% to 2,800 units, while SUV sales grew 2.4% to 70,260 units from last year.

At the end of September, Ford's highly anticipated new Maverick pickup posted its first sales report with 506 sold.

Overall F-Series sales continued to expand, marking its best month since the semiconductor shortage began with 63,164 sold. F-Series continued to expand its lead as America's best-selling truck for 2021.

Ford said its electrified vehicle sales produced a new all-time monthly sales record of 9,150, up 91.6 percent from last year. Mustang Mach-E sales totaled 1,578.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT